Adiponectin and vascular properties in obese patients: is it a novel biomarker of early atherosclerosis?

被引:49
|
作者
Shargorodsky, M. [1 ,2 ,3 ]
Boaz, M. [2 ,4 ]
Goldberg, Y. [2 ,3 ,5 ]
Matas, Z. [2 ,6 ]
Gavish, D. [2 ,3 ,5 ]
Fux, A. [6 ]
Wolfson, N. [2 ,3 ,5 ]
机构
[1] Wolfson Med Ctr, Dept Endocrinol, IL-58100 Holon, Israel
[2] Wolfson Med Ctr, Brunner Inst Cardiovasc Res, IL-58100 Holon, Israel
[3] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
[4] Wolfson Med Ctr, Dept Epidemiol & Stat, IL-58100 Holon, Israel
[5] Wolfson Med Ctr, Dept Med, IL-58100 Holon, Israel
[6] Wolfson Med Ctr, Dept Biochem, IL-58100 Holon, Israel
关键词
adiponectin; insulin resistance; subclinical atherosclerosis; intima media thickness; arterial elasticity; INTIMA-MEDIA THICKNESS; HOMEOSTASIS MODEL ASSESSMENT; INSULIN-RESISTANCE; CAROTID-ARTERY; RISK-FACTOR; CARDIOVASCULAR-DISEASE; INDEPENDENT PREDICTOR; GLUCOSE-TOLERANCE; SENSITIVITY; MORPHOLOGY;
D O I
10.1038/ijo.2009.37
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Adiponectin is an adipocyte-derived collagen-like protein, highly specific to adipose tissue and may represent an important link between obesity and atherosclerosis. The present study was designed to investigate a possible association between serum adiponectin levels and early vascular changes in obese patients as determined by intima media thickness (IMT) and arterial pulse-wave contour analysis. Design: Obese subjects (n = 47) were evaluated for arterial structure and function, metabolic parameters and serum adiponectin levels. Measurements: IMT was measured by ultrasound. Arterial elasticity was evaluated using pulse-wave contour analysis. Insulin resistance was assessed by homeostasis model assessment (HOMA-IR). Results: Adiponectin was significantly, inversely associated with mean IMT (r = -0.369, P = 0.011) and significantly positively associated with large artery elasticity index (LAEI) (r = 0.467, P = 0.001) as well as small artery elasticity index (SAEI) (r = 0.462, P = 0.001). In separate multivariate models, adiponectin remained significantly associated with mean IMT, LAEI and SAEI even after adjustment for cardiovascular confounders. Among metabolic parameters, adiponectin was significantly positively associated with HDL cholesterol and inversely associated with triglycerides. Adiponectin was significantly inversely associated with fasting insulin and HOMA-IR. In addition, a marginally inverse association between adiponectin and ALT was observed. Conclusions: In this study, serum adiponectin levels were significantly associated with indices of subclinical atherosclerosis, such as IMT and arterial compliance in obese patients. This association was independent of traditional cardiovascular risk factors. International Journal of Obesity (2009) 33, 553-558; doi:10.1038/ijo.2009.37; published online 24 February 2009
引用
收藏
页码:553 / 558
页数:6
相关论文
共 50 条
  • [21] Is serum Interleukin-17 associated with early atherosclerosis in obese patients?
    Tarantino, Giovanni
    Costantini, Susan
    Finelli, Carmine
    Capone, Francesca
    Guerriero, Eliana
    La Sala, Nicolina
    Gioia, Saverio
    Castello, Giuseppe
    JOURNAL OF TRANSLATIONAL MEDICINE, 2014, 12
  • [22] CAPILLAROSCOPIC OBSERVATION AS EARLY BIOMARKER OF ATHEROSCLEROSIS IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS
    Opoka-Winiarska, V.
    Korobowicz-Markiewicz, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 1103 - 1103
  • [23] It Is Too Early to Consider Serum Bilirubin as a Definitive Novel Biomarker for Carotid Atherosclerosis
    Qin, Lu
    Wang, Haoyuan
    Zhou, Wanru
    Wang, Hebo
    ANGIOLOGY, 2024, 75 (10) : 1000 - 1000
  • [24] Subclinical atherosclerosis, physical fitness and adiponectin levels in Italian obese children
    Invitti, C.
    Pasqualinotto, L.
    Di Matteo, S.
    Croci, M.
    Gilardini, L.
    Caffetto, K.
    Alberti, L.
    INTERNATIONAL JOURNAL OF OBESITY, 2006, 30 : S23 - S23
  • [25] Serum adiponectin regulates vascular O2-generation and NO bioavailability in patients with coronary atherosclerosis
    Antoniades, C.
    Shirodaria, C.
    Leeson, P.
    Bakogiannis, C.
    Demosthenous, M.
    Antonopoulos, A.
    Tousoulis, D.
    Miliou, A.
    Stefanadis, C.
    Channon, K. M.
    EUROPEAN HEART JOURNAL, 2010, 31 : 11 - 11
  • [26] ATHEROSCLEROSIS IN OBESE PATIENTS AT AUTOPSY
    ROBERTS, JC
    WILKINS, RH
    CIRCULATION, 1958, 18 (03) : 495 - 495
  • [27] Novel methodologies for biomarker discovery in atherosclerosis
    Hoefer, Imo E.
    Steffens, Sabine
    Ala-Korpela, Mika
    Baeck, Magnus
    Badimon, Lina
    Bochaton-Piallat, Marie-Luce
    Boulanger, Chantal M.
    Caligiuri, Giuseppina
    Dimmeler, Stefanie
    Egido, Jesus
    Evans, Paul C.
    Guzik, Tomasz
    Kwak, Brenda R.
    Landmesser, Ulf
    Mayr, Manuel
    Monaco, Claudia
    Pasterkamp, Gerard
    Tunon, Jose
    Weber, Christian
    EUROPEAN HEART JOURNAL, 2015, 36 (39) : 2635 - +
  • [28] Novel biomarker for pulmonary vascular disease in systemic sclerosis patients
    Favoino, E.
    Catacchio, G.
    Mininni, A.
    Ruscitti, P.
    Riccieri, V.
    Liakouli, V.
    Corrado, A.
    Navarini, L.
    Ciccia, F.
    Cipriani, P.
    Cantatore, F. P.
    Valesini, G.
    Giacomelli, R.
    Perosa, F.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (10) : 1956 - 1963
  • [29] The effects of adiponectin and inflammatory cytokines on diabetic vascular complications in obese and non-obese patients with type 2 diabetes mellitus
    Hong, Seong Bin
    Lee, Jung Jin
    Kim, So Hun
    Suh, Young Ju
    Han, Ju Young
    Kim, Yong Seong
    Nam, Moonsuk
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 111 : 58 - 65
  • [30] Can Adiponectin be a Novel Metabolic Biomarker for Heart Failure?
    Okamoto, Hiroshi
    CIRCULATION JOURNAL, 2009, 73 (06) : 1012 - 1013